Schedule 13D ownership disclosure

REVIVA PHARMACEUTCLS HLDGS I

Common Stock, par value $0.0001 per share · CUSIP: 76152G100

Event date: 2024-12-18

Filing-level shares
3,198,242.00
Percent of class
6.8%
  • Bhat LaxminarayanReported CIK 0001818245

    Shares: 3,198,242.00 · Class: 6.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-24-038128
Form type
SCHEDULE 13D/A
Filer
Bhat Laxminarayan
CIK
CIK 1818245
Filed
Dec 20, 2024
Reporting period
Dec 18, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub